Notably, as compared to CSF Aβ1-42 levels, p-tau/Aβ1-42 ratio revealed a lower sensitivity with regard to the clinical AD diagnosis, but a slight higher specificity in differentiating the other forms of dementia, except FTD. This evidence concerns the gene MAPT and Alzheimer disease.